John Morser

14.7k total citations · 4 hit papers
168 papers, 12.1k citations indexed

About

John Morser is a scholar working on Hematology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, John Morser has authored 168 papers receiving a total of 12.1k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Hematology, 49 papers in Molecular Biology and 30 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in John Morser's work include Blood Coagulation and Thrombosis Mechanisms (61 papers), Protease and Inhibitor Mechanisms (22 papers) and Venous Thromboembolism Diagnosis and Management (15 papers). John Morser is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (61 papers), Protease and Inhibitor Mechanisms (22 papers) and Venous Thromboembolism Diagnosis and Management (15 papers). John Morser collaborates with scholars based in United States, United Kingdom and Japan. John Morser's co-authors include Mariko Nagashima, Ann Marie Schmidt, Timothy Slattery, Qingyu Wu, Michael E. Nesheim, Peter P. Nawroth, Laszlo Bajzar, Faye Wu, David M. Stern and Lawrence Leung and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

John Morser

162 papers receiving 11.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease

1996 1.7k citations Mariko Nagashima, John Morser et al. profile →
RAGE Mediates a Novel Proinflammatory Axis

1999 1.6k citations Angelika Bierhaus, Peter P. Nawroth et al. profile →
The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin

1995 988 citations Mariko Nagashima, John Morser et al. Journal of Biological Chemistry profile →
TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin Complex

1996 506 citations John Morser, Michael E. Nesheim et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by John Morser

Since Specialization

Citations

This map shows the geographic impact of John Morser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Morser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Morser more than expected).

Fields of papers citing papers by John Morser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Morser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Morser. The network helps show where John Morser may publish in the future.

Co-authorship network of co-authors of John Morser

This figure shows the co-authorship network connecting the top 25 collaborators of John Morser. A scholar is included among the top collaborators of John Morser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Morser. John Morser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chemerin in Participants with or without Insulin Resistance and Diabetes 2024 ·Biomedicines ·Lei Zhao, (unknown), Fahim Abbasi, Mohsen Fathzadeh, Joshua W. Knowles, Lawrence Leung, John Morser	5
2	Thrombin cleavage of osteopontin initiates osteopontin’s tumor‐promoting activity 2022 ·Journal of Thrombosis and Haemostasis ·(unknown), Qi Zhou, (unknown), (unknown), Lei Zhao, Toshihiko Nishimura, Thomas Leung, Seiya Mizuno, Mamoru Ito, Timothy Myles, Thomas M. Stulnig, John Morser, Lawrence Leung	18
3	Both plasma basic carboxypeptidases, carboxypeptidase B2 and carboxypeptidase N, regulate vascular leakage activity in mice 2021 ·Journal of Thrombosis and Haemostasis ·(unknown), Lei Zhao, Zhifei Shao, Paul Declerck, Lawrence Leung, John Morser	2
4	TAFI deficiency causes maladaptive vascular remodeling after hemophilic joint bleeding 2019 ·JCI Insight ·Tine Wyseure, Tingyi Yang, (unknown), (unknown), (unknown), Merissa Olmer, (unknown), Yosuke Morodomi, Niels Behrendt, Martin Lotz, John Morser, Annette von Drygalski, Laurent O. Mosnier	6
5	Antibody-mediated targeting of cleavage-specific OPN-T cell interactions 2019 ·PLoS ONE ·(unknown), Matteo Tardelli, (unknown), Angelika Neuhofer, Gerhard Prager, John Morser, Lawrence Leung, Günther Staffler, Maximilian Zeyda, Thomas M. Stulnig	3
6	Evaluation of and recommendation for the nomenclature of the CPB2 gene product (also known as TAFI and proCPU): communication from the SSC of the ISTH 2015 ·Journal of Thrombosis and Haemostasis ·Jonathan H. Foley, (unknown), Dirk Hendriks, John Morser, Ann Gils, Nicola J. Mutch	12
7	Thrombin-Activatable Fibrinolysis Inhibitor Protects against Acute Lung Injury by Inhibiting the Complement System 2013 ·American Journal of Respiratory Cell and Molecular Biology ·Masahiro Naito, Osamu Taguchi, Tetsu Kobayashi, Takehiro Takagi, Corina N. D’Alessandro‐Gabazza, Yuki Matsushima, (unknown), Paloma Gil-Bernabe, Takahiro Μatsumoto, (unknown), Masaaki Toda, Atsushi Yasukawa, Osamu Hataji, John Morser, Yoshiyuki Takei, Esteban C. Gabazza	23
8	Activated Thrombin-Activatable Fibrinolysis Inhibitor (TAFIa) Levels are decreased in Patients With Trauma-Induced Coagulopathy 2012 ·Thrombosis Research ·Thomas Lustenberger, Borna Relja, (unknown), Esteban C. Gabazza, (unknown), Yoshio Takei, John Morser, İngo Marzi	12
9	High incidence of tumors in diabetic thrombin activatable fibrinolysis inhibitor and apolipoprotein E double‐deficient mice 2010 ·Journal of Thrombosis and Haemostasis ·(unknown), Paloma Gil-Bernabe, (unknown), Corina N. D’Alessandro‐Gabazza, Y. Matsuda, Masaaki Toda, Yohei Miyake, (unknown), Mariko Murata, T Murata, Yutaka Yano, John Morser, Esteban C. Gabazza, Yoshio Takei	8
10	Inhibition of Allergic Bronchial Asthma by Thrombomodulin Is Mediated by Dendritic Cells 2010 ·American Journal of Respiratory and Critical Care Medicine ·Takehiro Takagi, Osamu Taguchi, Masaaki Toda, (unknown), (unknown), Corina N. D’Alessandro‐Gabazza, Yasushi Miyake, Tetsu Kobayashi, Shinya Aoki, Fumiko Chiba, Yutaka Yano, Edward M. Conway, Seiichi Munesue, Yasuhiko Yamamoto, Hiroshi Yamamoto, Koji Suzuki, Yoshiyuki Takei, John Morser, Esteban C. Gabazza	39
11	A case of fulminant type 1 diabetes with coxsackie B4 virus infection diagnosed by elevated serum levels of neutralizing antibody 2009 ·Diabetes Research and Clinical Practice ·(unknown), Yutaka Yano, Esteban C. Gabazza, John Morser, (unknown), Toshinari Suzuki, Ryoko Fujiwara, Akira Katsuki, Yoshiyuki Takei, Yasuhiro Sumida	27
12	3-Mercaptopropionic acids as efficacious inhibitors of activated thrombin activatable fibrinolysis inhibitor (TAFIa) 2006 ·Bioorganic & Medicinal Chemistry Letters ·Imadul Islam, Judi Bryant, Karen May, Raju Mohan, Shendong Yuan, (unknown), John Morser, Lei Zhao, Ron Vergona, Kathy White, Marc Adler, Marc Whitlow, Brad O. Buckman	25
13	The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte Integrins 2003 ·The Journal of Experimental Medicine ·Triantafyllos Chavakis, Angelika Bierhaus, Nadia Al‐Fakhri, Darius Schneider, Steffen Witte, Thomas Linn, Mariko Nagashima, John Morser, Bernd Arnold, Klaus T. Preissner, Peter P. Nawroth	489
14	Discovery and characterization of a potent and selective non-amidine inhibitor of human factor Xa 2003 ·Biochemical Pharmacology ·Amy Liang, David R. Light, Monica J. Kochanny, Galina Rumennik, Lan Trinh, Dao Lentz, Joseph Post, John Morser, (unknown)	6
15	Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life 2002 ·Journal of Clinical Investigation ·Mariko Nagashima, (unknown), Lei Zhao, Kathy White, Yanhong Zhu, Nina Lasky, Meredith Halks‐Miller, George Broze, William P. Fay, John Morser	4
16	Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life 2002 ·Journal of Clinical Investigation ·Mariko Nagashima, (unknown), Lei Zhao, Kathy White, Yanhong Zhu, Nina Lasky, Meredith Halks‐Miller, George Broze, William P. Fay, John Morser	103
17	Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life 2002 ·Journal of Clinical Investigation ·Mariko Nagashima, (unknown), Lei Zhao, Kathy White, Yanhong Zhu, Nina Lasky, Meredith Halks‐Miller, George Broze, William P. Fay, John Morser	116
18	Elements of the Primary Structure of Thrombomodulin Required for Efficient Thrombin-activable Fibrinolysis Inhibitor Activation 2000 ·Journal of Biological Chemistry ·Wei Wang, Mariko Nagashima, Mark Schneider, John Morser, Michael E. Nesheim	81
19	Thrombomodulin activity and localization 1993 ·The International Journal of Developmental Biology ·Louis M. Fink, John F. Eidt, (unknown), James M. Cook, (unknown), John Morser, Richard A. Marlar, (unknown), Robert F. Schaefer, Su Xie	28
20	SHORT COMMUNICATION: Effects of Sodium Butyrate on a Human Lymphoblastoid Cell Line (Namalwa) and its Interferon Production 1980 ·Journal of Interferon Research ·Philip N. Baker, John Morser, D. C. Burke	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact